EX-23.1 3 grtx-ex23_1.htm EX-23.1

Exhibit 23.1

Consent of Independent Registered Public Accounting Firm

We consent to the incorporation by reference in the registration statements (No. 333-251061) on Form S-3 and (No. 333-234607) on Form S-8 of our report dated March 10, 2022, with respect to the consolidated financial statements of Galera Therapeutics, Inc.

/s/ KPMG LLP

Philadelphia, Pennsylvania
March 10, 2022